Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2014 IEEE International Conference on Bioinformatics and Bioengineering 2014
DOI: 10.1109/bibe.2014.40
|View full text |Cite
|
Sign up to set email alerts
|

Delayed and Hidden Variables Interactions in Gene Regulatory Networks

Abstract: Reverse Engineering of Gene Regulatory Networks (GRN), i.e. finding appropriate mathematical models to understand complex cellular systems, can be used in disease diagnosis, treatment, and drug design. There are fundamental gaps in the construction of GRN with regard to modeling of hidden/delayed interactions. Addressing these deficiencies is critical to understanding complex intracellular processes and enabling full use of the vast and ever-growing amount of available genomic data. Current modeling strategies… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2016
2016

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…GRNs typically contain information about the pathway to which a gene belongs and the genes it interacts with [ 16 ], and this helps to reveal potential pathway initiators and drug targets [ 8 ]. Further analysis, to map interactions among phenotypic and genotypic characteristics, can provide a framework for the identification of biomarkers for medical diagnosis and prognosis [ 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…GRNs typically contain information about the pathway to which a gene belongs and the genes it interacts with [ 16 ], and this helps to reveal potential pathway initiators and drug targets [ 8 ]. Further analysis, to map interactions among phenotypic and genotypic characteristics, can provide a framework for the identification of biomarkers for medical diagnosis and prognosis [ 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%